Eli Lilly (NYSE: LLY) stock was the picture of health on Friday. Shares of the massive American pharmaceutical company rose ...

Novo Nordisk's phase 1b/2a clinical trial results revealed that their investigational drug, amycretin, led to an average ...

An experimental drug called amycretin showed signs it could be more potent than Eli Lilly’s rival Zepbound, though analysts ...

The Danish pharma giant posted impressive data for amycretin one month after the disappointing readout of CagriSema.

Generally, you can count on drugmakers for a steady revenue performance -- since patients need their medicines, revenue holds ...

BofA Securities maintained a Buy rating on Eli Lilly stock (NYSE:LLY), with a price target set at $997.00. With a market capitalization of $706 billion and impressive revenue growth of 27.4% over the ...

Allurion catapulted nearly 200% early Friday after the company said it plans to test its weight-loss technology with an ...

Carnival Freedom was supposed to embark on a Bahamas cruise on January 23 - but remains stuck in port due to an environmental issue.